Ryvu Therapeutics S.A. (WSE:RVU)

Splunk Revenue

Ryvu Therapeutics had revenue of 21.03M PLN in the quarter ending March 31, 2025, a decrease of -17.27%. This brings the company's revenue in the last twelve months to 97.57M, up 31.13% year-over-year. In the year 2024, Ryvu Therapeutics had annual revenue of 101.96M with 51.51% growth.

• Revenue (ttm): 97.57M
• Revenue Growth: +31.13%
• P/S Ratio: 7.27
• Revenue / Employee: 297.47K
• Employees: 328
• Market Cap: 709.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	101.96M	34.67M	51.51%
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%
Dec 31, 2020	36.95M	3.23M	9.58%